Breast tumor kinase (Brk/PTK6) was overexpressed in over 80% of breast cancers and is associated with poor patient outcomes.PTK6 protein expression is associated with different prognosis indifferent tumor types. This evidence concerns the gene PTK6 and breast cancer.